Cost-effectiveness and cost-utility of hypertension and hyperlipidemia collaborative management between pharmacies and primary care in portugal alongside a trial compared with usual care (USFarmácia®)

Funding Information: The trial was promoted by the NHS Group of Primary Care Units [Agrupamento dos Centros de Saúde, or ACeS] of Baixo Mondego Region and the Portuguese National Association of Pharmacies [Associação Nacional das Farmácias, or ANF] and was funded by ANF. Study promoters and funders...

Full description

Bibliographic Details
Main Author: Costa, Suzete (author)
Other Authors: Guerreiro, José (author), Teixeira, Inês (author), Helling, Dennis K. (author), Pereira, João (author), Mateus, Céu (author)
Format: article
Language:eng
Published: 2022
Subjects:
community pharmacy
cost-effectiveness
cost-utility
economic
hyperlipidemia
hypertension
primary care
real-world
Pharmacology
Pharmacology (medical)
SDG 3 - Good Health and Well-being
Online Access:http://hdl.handle.net/10362/144662
Country:Portugal
Oai:oai:run.unl.pt:10362/144662
Description
Summary:Funding Information: The trial was promoted by the NHS Group of Primary Care Units [Agrupamento dos Centros de Saúde, or ACeS] of Baixo Mondego Region and the Portuguese National Association of Pharmacies [Associação Nacional das Farmácias, or ANF] and was funded by ANF. Study promoters and funders had no role in the design and conduct of the trial/study; collection, management, analysis, and interpretation of data; and writing, review, approval, or decision to submit this manuscript for publication. SC paid for the open access publication fee for this manuscript. Publisher Copyright: Copyright © 2022 Costa, Guerreiro, Teixeira, Helling, Pereira and Mateus.

Similar Items